A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products

Biology of Blood and Marrow Transplantation

Volumn 10, Issue 12, 2004, Pages 848-857

  Lonial, Sagar ^a,b   Hicks, Michelle ^a   Rosenthal, Hilary ^a   Langston, Amelia ^a   Redei, Istvan ^a   Torre, Claire ^a   Duenzl, Mary ^a   Feinstein, Bonita ^a   Cherry, Judith ^a   Waller, Edmund K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Cytokine modulation; Dendritic cell subsets; Stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; INTERLEUKIN 12; INTERLEUKIN 4; METHYLPREDNISOLONE; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE;

ADULT; AGED; APHERESIS; ARTICLE; BONE PAIN; CELL POLARITY; CELLULAR IMMUNITY; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ERYTHEMA; FEMALE; FEVER; FLOW CYTOMETRY; HEADACHE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; LYMPHOMA; MALE; MULTIPLE MYELOMA; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STEM CELL MOBILIZATION; T LYMPHOCYTE SUBPOPULATION;

EID: 10344248963     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2004.07.008     Document Type: Article

References (33)

1. A. Lanzavecchia F. Sallusto The instructive role of dendritic cells on T cell responses: Lineages, plasticity and kinetics Curr Opin Immunol 13 2001 291-298
2. L. Fong E.G. Engleman Dendritic cells in cancer immunotherapy Annu Rev Immunol 18 2000 245-273
3. S. Robinson S. Patterson N. English D. Davies S. Knight C. Reid Human peripheral blood contains two distinct lineages of dendritic cells Eur J Immunol 29 1999 2769-2778
4. J. Olweus A. BitMansour R. Warnke et al. Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin Proc Natl Acad Sci U S A 94 1997 12551-12556
5. A. Ellis C. Torre E.K. Waller S. Lonial Dendritic Cell Subtypes Significantly Enhance or Inhibit Autologous T-Cell Responses against Alloantigen 2002 American Association of Cancer Research San Francisco, CA
6. M.C. Rissoan V. Soumelis I.N. Kadowak et al. Reciprocal control of T helper cell and dendritic cell differentiation Science 283 1999 1183-1186
7. J.R. Lee R.R. Dalton J.L. Messina et al. Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma Lab Invest 83 2003 1457-1466
8. E. Waller H. Rosenthal T. Jones et al. Larger numbers of CD4bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation Blood 97 2001 2948-2956
9. M. Arpinati C.L. Green S. Heimfield J.E. Heuser C. Anasettis Granulocyte-colony stimulating factor mobilizes T helper-2-inducing dendritic cells Blood 95 2000 2484-2490
10. R.E. Ryncarz C. Anasetti Expression of CD86 on human marrow CD34(+) cells identifies immunocompetent committed precursors of macrophages and dendritic cells Blood 91 1998 3892-3900
11. G. Milone S. Leotta F. Indelicato et al. G-CSF alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: Results depend on degree of previous pretreatment Bone Marrow Transplant 31 2003 747-754
12. C.H. Moskowitz J.R. Bertino J.R. Glassman et al. Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma J Clin Oncol 17 1999 3776-3785
13. W.S. Velasquez P. McLaughlin S. Tucker et al. ESHAP - an effective chemotherapy regimen in refractory and relapsing lymphoma a 4-year follow-up study J Clin Oncol 12 1994 1169-1176
14. N. Kroger S. Sonnenberg L. Cortes-Dericks P. Freiberger H. Mollnau A.R. Zander Kinetics of G-CSF and CD34+ cell mobilization after once or twice daily stimulation with rHu granulocyte-stimulating factor (lenograstim) in healthy volunteers: An intraindividual crossover study Transfusion 44 2004 104-110
15. N. Kroger W. Zeller H.T. Hassan et al. Stem cell mobilization with G-CSF alone in breast cancer patients: Higher progenitor cell yield by delivering divided doses (2 × 5 microg/kg) compared to a single dose (1 × 10 microg/kg) Bone Marrow Transplant 23 1999 125-129
16. J. Sevilla M. Gonzalez-Vicent L. Madero F. Garcia-Sanchez M.A. Diaz Granulocyte colony-stimulating factor alone at 12 microg/kg twice a day for 4 days for peripheral blood progenitor cell priming in pediatric patients Bone Marrow Transplant 30 2002 417-420
17. S. Lonial T.W. Jones S. Devine et al. High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma Leuk Lymphoma 36 2000 497-502
18. E.K. Waller J. Olweus F. Lund-Johansen et al. The "common stem cell" hypothesis reevaluated: Human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors Blood 85 1995 2422-2435
19. I.F. Khouri J. Romaguera H. Kantarjian et al. Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma J Clin Oncol 16 1998 3803-3809
20. T. Kewalramani A.D. Zelenetz S.D. Nimer et al. Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma Blood 103 2004 3684-3688
21. S.D. Rowley M. Loken J. Radich et al. Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system Bone Marrow Transplant 21 1998 1253-1262
22. L.L. Carter S.L. Swain Single cell analyses of cytokine production Curr Opin Immunol 9 1997 177-182
23. S.M. Devine D.R. Adkins H. Khoury et al. Mobilization of Donors with GM-CSF Plus G-CSF or GM-CSF Alone Results in Significantly Different Graft Composition Compared to G-CSF Alone American Society of Hematology 2002 American Society of Hematology Philadelphia 825a
24. I. Volpi K. Perruccio A. Tosti et al. Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants Blood 97 2001 2514-2521
25. F. Aversa A. Tabilo A. Velardi et al. Treatment of high-risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched HLA haplotype N Engl J Med 339 1998 1186-1193
26. O. Ringden M. Labopin N.C. Gorin et al. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: A study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation J Clin Oncol 22 2004 416-423
27. M. Arpinati G. Chirumbolo B. Urbini Infusion of High Numbers of G-CSF Mobilized Blood Dendritic Cells Type 2 (DC2) Is Associated with an Increased Rate of Chronic GvHD in Allogeneic PBSC Transplantation. American Society of Hematology 2002 American Society of Hematology Philadelphia 113a
28. S. Avery G.M. Bollard A. Spencer A.P. Schwarer Type 2 Dendritic Cell (DC2) Content in Donor Peripheral Blood Stem Cell (PBSC) Grafts Is Associated with Improved Survival following Allogeneic Transplantation. American Society of Hematology 2002 American Society of Hematology Philadelphia 39a
29. S.P. Gladney E.K. Waller I. Redei A.A. Langston S. Lonial Effect of Donor Dendritic Cells on Overall Survival and Incidence of GvHD after Allogeneic HPCT from HLA Matched Sibling Donors. American Society of Hematology 2002 American Society of Hematology Philadelphia 420a
30. R.A. Brown Novel strategies for mobilization of allogeneic peripheral blood stem cells Immun Enhancing Cytokines 2 2001 8-11
31. S. Lonial C. Torre M. Hicks et al. Modulation of Allogeneic PBPC Graft Contents Using G-CSF or G-CSF+GM-CSF: Preliminary Results from a Randomized Clinical Trial 2003 American Society of Hematology San Diego, CA 953a
32. Y.J. Liu B. Blom Introduction: TH2-inducing DC2 for immunotherapy Blood 95 2000 2482-2483
33. J.F. DiPersio H. Khoury J. Haug et al. Innovations in allogeneic stem-cell transplantation Semin Hematol 37 2000 33-41